Sickle cell disease trials in Japan

1 trial · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 4Enrolling by invitation
  A Study to Provide Access to Mitapivat for Participants Who Previously Participated in an Agios-Sponsored Mitapivat Study

  Where

  Kyoto, Ōta-ku, Sendai

  Age

  18 years and over

  People

  55 worldwide

  Run by

  Agios Pharmaceuticals, Inc.

  See details and how to joinNCT05777993 · EU 2026-526243-35-00